Assembly Biosciences Inc  

(Public, NASDAQ:ASMB)   Watch this stock  
Find more results for NASDAQ:VTUS
0.00 (0.00%)
Nov 25 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 6.51 - 20.50
Open     -
Vol / Avg. 0.00/62,384.00
Mkt cap 167.09M
P/E     -
Div/yield     -
EPS -2.02
Shares 17.23M
Beta 0.65
Inst. own 72%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -18.67% -48.37%
Return on average equity -20.72% -57.28%
Employees 10 -
CDP Score - -


99 Hudson St Fl 5
NEW YORK, NY 10013-2993
United States - Map
+1-212-5544388 (Phone)
+1-646-7065101 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Assembly Biosciences, Inc. (Assembly) is a biopharmaceutical company. The Company is engaged in the development of oral therapies for the cure of intractable infectious diseases, focusing on hepatitis B virus (HBV) and clostridium (C.) difficile-associated infections (CDAD). The target of Assembly's lead program is a clinical cure for HBV, for , which it is developing a series of compounds, known as core protein allosteric modulators (CpAMs). Assembly's clinical strategy includes testing CpAMs as monotherapy and in combination. Assembly's CDAD program is -based on the targeted delivery of microbiome-based therapies in an oral formulation, applying Assembly's coating and encapsulation technology that allows for targeted delivery of complex agents to select regions of the gastrointestinal (GI) tract. The Company's HBV and microbiome therapies are both in pre-clinical development stages.

Officers and directors

Derek A. Small President, Chief Executive Officer, Director
Age: 39
Bio & Compensation  - Reuters
David J. Barrett CPA, Chief Financial Officer, Chief Operating Officer
Age: 39
Bio & Compensation  - Reuters
Lee D. Arnold Chief Scientific Officer
Age: 55
Bio & Compensation  - Reuters
Uri Lopatin M.D. Vice President - Research & Development, Chief Medical Officer
Age: 43
Bio & Compensation  - Reuters
William Ringo Independent Non-Executive Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Anthony E. Altig Independent Director
Age: 59
Bio & Compensation  - Reuters
Mark Auerbach CPA, Independent Director
Age: 76
Bio & Compensation  - Reuters
Richard DiMarchi Independent Director
Age: 62
Bio & Compensation  - Reuters
Myron Z. Holubiak Independent Director
Age: 68
Bio & Compensation  - Reuters